References
- 1. A. C. Church, Clinical advances in therapies targeting the interleukin-2 receptor, QJM: Int. J. Med.96 (2003) 91–102; https://doi.org/10.1093/qjmed/hcg01410.1093/qjmed/hcg01412589007
- 2. A. L. Moine, M. Goldman and D. Abramowicz, Multiple pathways to allograft rejection, Transplantation73 (2002) 1373–1381; https://doi.org/10.1097/00007890-200205150-0000110.1097/00007890-200205150-0000112023610
- 3. S. L. Gaffen and K. D. Liu, Overview of interleukin-2 function, production and clinical applications, Cytokine 28 (2004) 109–123; https://doi.org/10.1016/j.cyto.2004.06.01010.1016/j.cyto.2004.06.01015473953
- 4. M. R. Arkin and J. A. Wells, Small-molecule inhibitors of protein-protein interactions: progressing towards the dream, Nat. Rev. Drug Dis. 3 (2004) 301–317; https://doi.org/10.1038/nrd134310.1038/nrd134315060526
- 5. T. Dasgupta, P. Chitnumsub, S. Kamchonwongpaisan, C. Maneeruttanarungroj, S. E. Nichols, T. M. Lyons, J. Tirado-Rives, W. L. Jorgensen, Y. Yuthavong and K. S. Anderson, Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria, ACS Chem. Biol.4 (2009) 29–40; https://doi.org/10.1038/nrd134310.1038/nrd1343
- 6. C. Mc Innesa, Virtual screening strategies in drug discovery, Curr. Opin. Chem. Biol.11 (2007) 494–502; https://doi.org/10.1016/j.cbpa.2007.08.03310.1016/j.cbpa.2007.08.03317936059
- 7. S. A. Halim and Z. Ul-Haq, Structure based 3D-QSAR studies of interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations, Chem. Biol. Int. 238 (2015) 9–24; https://doi.org/10.1016/j.cbi.2015.05.01810.1016/j.cbi.2015.05.01826051521
- 8. S. A. Halim, O. M. Abdalla, M. A. Mesaik, A. Wadood, Z. Ul-Haq and M. Kontoyianni, Identification of novel interleukin-2 inhibitors through computational approaches, Mol. Div.17 (2013) 345–355; https://doi.org/10.1007/s11030-013-9431-410.1007/s11030-013-9431-423494734
- 9. S. A. Halim, M. Jawad, M. Ilyas, Z. Mir, A. A. Mirza and T. Husnain, In silico identification of novel IL-1β inhibitors to target protein–protein interfaces, Comp. Biol. Chem.58 (2015) 158–166; https://doi.org/10.1016/j.compbiolchem.2015.06.00410.1016/j.compbiolchem.2015.06.00426253030
- 10. E. S. H. E. Ashry, M. R. Amer, O. M. Abdalla, A. A. Aly, S. Soomro, A. Jabeen, S. A. Halim, M. A. Mesaik and Z. Ul-Haq, Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxocyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agents, Bioorg. Med. Chem.20 (2012) 3000–3008; https://doi.org/10.1016/j.bmc.2012.03.00310.1016/j.bmc.2012.03.00322480848
- 11. M. A. Mesaik, S. A. Halim, Z. Ul-Haq, M. I. Choudhary, S. Shahnaz, S. A. Ayatollahi, S. Murad and A. Ahmad, Immunosuppresive activity of buxidin and buxenone from Buxus hyrcana, Chem. Biol. Drug Des.75 (2010) 310–317; https://doi.org/10.1111/j.1747-0285.2009.00906.x10.1111/j.1747-0285.2009.00906.x20659112
- 12. M. A. Mesaik, A. Jabeen, S. A. Halim, A. Begum, A. S. Khalid, M. Asif, B. Fatima, Z. Ul-Haq and M. I. Choudhary, In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa, Chem. Biol. Drug Des.79 (2012) 290–299; https://doi.org/10.1111/j.1747-0285.2011.01310.x10.1111/j.1747-0285.2011.01310.x22181857
- 13. Saifullah, S. Khan, Azizudin, S. A. Halim, M. Kashif, A. Jabeen, M. Asif, M. A. Mesaik, Z. Ul-Haq, A. Dar and M. I. Choudhary, In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of dianabol through Azadirachta indica and its molecular docking studies, Chem. Cent. J.7 (2013) Article ID 163 (11 pages); https://doi.org/10.1186/1752-153X-7-16310.1186/1752-153X-7-163387477824764465
- 14. G. B. McGaughey, R. P. Sheridan, C. I. Bayly, J. C. Culberson, C. Kreatsoulas, S. Lindsley, V. Maiorov, J. F. Truchon and W. D. Cornell, Comparison of topological, shape, and docking methods in virtual screening, J. Chem. Inf. Model.47 (2007) 1504–1519; https://doi.org/10.1021/ci700052x10.1021/ci700052x17591764
- 15. M. R. McGann, H. R. Almond, A. Nicholls, J. A. Grant and F. K. Brown, Gaussian docking functions, Biopolymers68 (2003) 76–90; https://doi.org/10.1002/bip.1020710.1002/bip.1020712579581
- 16. G. Jones, P. Willett, R. C. Glen, A. R. Leach and R. J. Taylor, Development and validation of a genetic algorithm for flexible docking, Mol. Biol.267 (1997) 727-748; https://doi.org/10.1006/jmbi.1996.089710.1006/jmbi.1996.08979126849
- 17. A. N. Jain, Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine, J. Med. Chem.46 (2003) 499–511; https://doi.org/10.1021/jm020406h10.1021/jm020406h12570372
- 18. MOE v2006.08 (2006) Chemical Computing Group Inc., 910-1010 Sherbrooke St. W. Montreal, QC H3A 2R7 Canada; https://www.chemcomp.com/
- 19. H. Edelsbrunner, Weighted Alpha Shapes, Technical Report UIUCDCS-R-92-1760, Department of Computer Science, University of Illinois at Urbana-Champaign (IL) USA, 1992.
- 20. J. J. Irwin and B. K. Shoichet, ZINC-a free database of commercially available compounds for virtual screening, J. Chem. Inf. Model.45 (2005) 177–182; https://doi.org/10.1021/ci049714+10.1021/ci049714+136065615667143
- 21. SYBYL molecular modeling program version 7.3 (2007) Tripos Associates Inc., St. Louis (MO) USA; http://www.tripos.com/sybyl/
- 22. GOLD Protein Ligand Docking Software version 3.2 (2008) Cambridge Crystallographic Data Center, Cambridge, UK; https://www.ccdc.cam.ac.uk/solutions/csd-discovery/components/gold/
- 23. M. D. Eldridge, C. W. Murray, T. R. Auton, G. V. Paolini and R. P. Mee, Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Comp. Aid. Mol. Des.11 (1997) 425–445; https://doi.org/10.1023/A:100799612454510.1023/A:1007996124545
- 24. G. M. Verkhivker, D. Bouzida, D. K. Gehlhaar, P. A. Rejto, S. Arthurs, A. B. Colson, S. T. Freer, V. Larson, B. A. Luty, T. Marrone and P. W. Rose, Deciphering common failures in molecular docking of ligand-protein complexes, J. Comp. Aid. Mol. Des.14 (2000) 731–751; https://doi.org/10.1023/A:100815823155810.1023/A:1008158231558
- 25. M. Stahl and M. Rarey, Detailed analysis of scoring functions for virtual screening, J. Med. Chem.44 (2001) 1035–1042; https://doi.org/10.1021/jm000399210.1021/jm0003992
- 26. W. Welch, J. Ruppert and A. N. Jain, Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites, Chem. Biol.3 (1996) 449–462.
- 27. M. R. Arkin, M. Randal, W. L. DeLano, J. Hyde, T. N. Luong, J. D. Oslob, D. R. Raphael, L. Taylor, J. Wang, R. S. McDowell, J. A. Wells and A. C. Braisted, Binding of small molecules to an adaptive protein–protein interface, Proc. Nat. Acad. Sci. USA100 (2003) 1603–1608; https://doi.org/10.1073/pnas.25275629910.1073/pnas.252756299
- 28. C. D. Thanos, M. Randal and J. A. Wells, Potent small-molecule binding to a dynamic hot spot on IL-2, J. Am. Chem. Soc.25 (2003) 15280–15281; https://doi.org/10.1021/ja038261710.1021/ja0382617
- 29. M. Clark, R. D. Cramer III and N. Van Opdenbosch, Validation of the general purpose tripos 5.2 force field, J. Comp. Chem.10 (1989) 982–1012; https://doi.org/10.1002/jcc.54010080410.1002/jcc.540100804
- 30. T. A. Halgren, Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions, J. Comp. Chem.17 (1996) 520–552; https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W
- 31. T. A. Halgren, MMFF VI. MMFF94s option for energy minimization studies, J. Comp. Chem.20 (1999) 720–729; https://doi.org/10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X
- 32. J. Boström, J. R. Greenwood and J. Gottfries, Assessing the performance of OMEGA with respect to retrieving bioactive conformations, J. Mol. Graph. Model.21 (2003) 449–462; https://doi.org/10.1016/S1093-3263(02)00204-810.1016/S1093-3263(02)00204-8
- 33. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Del. Rev.23 (1997) 3–25; https://doi.org/10.1016/S0169-409X(00)00129-010.1016/S0169-409X(00)00129-0
- 34. R. Wang, Y. Fu and L. Lai, A new atom-additive method for calculating partition coefficients, J. Chem. Inf. Model.37 (1997) 615–621; https://doi.org/10.1021/ci960169p10.1021/ci960169p
- 35. Y. C. Martin, A bioavailability score, J. Med. Chem.48 (2005) 3164–3170; https://doi.org/10.1021/jm049200210.1021/jm0492002
- 36. A. C. Braisted, J. D. Oslob, W. L. Delano, J. Hyde, R. S. McDowell, N. Waal, C. Yu, M. R. Arkin and B. C. Raimundo, Discovery of a potent small molecule IL-2 inhibitor through fragment assembly, J. Am. Chem. Soc.125 (2003) 3714–3715; https://doi.org/10.1021/ja034247i10.1021/ja034247i
- 37. B. Geng, P. R. Fleming, S. Umlauf, A. Lin and P. V. Pallaia, The synthesis and selective IL-2 inhibitory activity of bis piperazine–phenol Mannich adducts, Bioorg. Med. Chem. Lett.12 (2002) 775–778; https://doi.org/10.1016/S0960-894X(02)00011-210.1016/S0960-894X(02)00011-2
- 38. B. C. Raimundo, J. D. Oslob, A. C. Braisted, J. Hyde, R. S. McDowell, M. Randal, N. D. Waal, J. Wilkinson, C. H. Yu and M. R. Arkin, Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions, J. Med. Chem.47 (2004) 3111–3130; https://doi.org/10.1021/jm049967u10.1021/jm049967u15163192
- 39. J. W. Tilley, L. Chen, D. C. Fry, S. D. Emerson, G. D. Powers, D. Biondi, T. Varnell, R. Trilles, R. Guthrie, F. Mennona, G. Kaplan, R. A. LeMahieu, M. Carson, R. J. Han, C. M. Liu, R. Palermo and G. Ju, Identification of a small molecule inhibitor of the IL-2/IL-2Rr receptor interaction which binds to IL-2, J. Am. Chem. Soc.119 (1997) 7589–7590; https://doi.org/10.1021/ja970702x10.1021/ja970702x
- 40. N. D. Waal, W. Yang, J. D. Oslob, M. R. Arkin, J. Hyde, W. Lu, R. S. McDowell, C. H. Yu and B. C. Raimundo, Identification of non-peptidic small-molecule inhibitors of interleukin-2, Bioorg. Med. Chem. Lett.15 (2005) 983–987; https://doi.org/10.1016/j.bmcl.2004.12.04510.1016/j.bmcl.2004.12.04515686897
- 41. N. Triballeau, F. Acher, I. Brabet, J. P. Pin and H. O. Bertrand, Virtual screening workflow development guided by the “Receiver Operating Characteristic” curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4, J. Med. Chem.48 (2005) 2534–2547; https://doi.org/10.1021/jm049092j10.1021/jm049092j15801843
- 42. I. Halperin, B. Ma, H. Wolfson and R. Nussinov, Principles of docking: an overview of search algorithms and a guide to scoring functions, Proteins47 (2002) 409–443; https://doi.org/10.1002/prot.1011510.1002/prot.1011512001221
- 43. Z. Ul-Haq, S. A. Halim, R. Uddin and J. D. Madura, Benchmarking docking and scoring protocol for the identification of potential acetylcholinesterase inhibitors, J. Mol. Graph. Model.28 (2010) 870–882; https://doi.org/10.1016/j.jmgm.2010.03.00710.1016/j.jmgm.2010.03.00720447848